The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2023

Filed:

Aug. 19, 2020
Applicant:

Rune Labs, Inc., San Francisco, CA (US);

Inventors:

Brian Marc Pepin, San Francisco, CA (US);

Miroslav Tchavdarov Kotzev, Pacifica, CA (US);

Assignee:

Rune Labs, Inc., San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06Q 10/00 (2023.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G06F 8/41 (2018.01); G06F 8/60 (2018.01); A61N 1/372 (2006.01); G16H 50/20 (2018.01); G16H 10/60 (2018.01);
U.S. Cl.
CPC ...
G16H 40/40 (2018.01); A61N 1/37264 (2013.01); G06F 8/44 (2013.01); G06F 8/60 (2013.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 10/60 (2018.01);
Abstract

Methods and systems are provided for generating specific software implementations of neuromodulation-therapy algorithms. A dataset may be received that includes operational specifications that correspond to a plurality of types of neuromodulation-therapy implant devices. A neuromodulation-therapy design interface may provide a representation of the neuromodulation-therapy implant device. A selection if a particular representation of a particular neuromodulation-therapy implant device may be received. Hardware characteristics of the particular neuromodulation-therapy implant device may be used to determine constraints of the implant device. A listing of neuromodulation-therapy parameters that is constraining according to the constraints may be presented. In response to a selection of a parameter, executable software code corresponding to a specific implementation of a neuromodulation-therapy algorithm may be generated. The executable software code may be transmitted to a computing device compatible with the specific implementation.


Find Patent Forward Citations

Loading…